Statins May Tackle Cancer
Cholesterol-lowering drugs may have a new use?reducing cancer, especially cancer of the kidney and prostate, according to the results of a Dutch study. The study, which looked at drug-dispensing records and hospital discharge records from 8 Dutch cities, found that statin use was connected with a 20% reduction in cancer risk.The researchers compared the use of statin drugs among 3219 patients with cancer and 16, 976 without cancer. All the participants were receiving at least 1 medication for cardiovascular disease.
Lead investigator Matthijs Graaf, PharmD, of the Academic Medical Center at the University of Amsterdam in the Netherlands, said, "People who used statins for less than 4 years did not have a significant risk reduction." The risk of cancer was 36% lower, however, in participants who took statins for at least 4 years, compared with that in people who did not take the drugs. Graaf stressed that more studies are needed before physicians advise patients to take statins solely as a means for decreasing the risk of cancer.

American Journal of Pharmacy Benefits
HCPLive
ONCLive
OTCGuide
PainLive
Pharmacy Times
Physician's Money Digest
EchoJournal
iMedicalApps
Medgadget
Medical Smartphones
Medicine and Technology
Mobile Health Computing
Non-Clinical Medical Jobs,
Careers, and Opportunities
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747
Copyright HCPLive 2006-2011
Intellisphere, LLC. All Rights Reserved.




Email
Print


